FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Jubilant Cadista Pharmaceuticals Pantoprazole Sodium Delayed-Release Tablets Recall

Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg, 90 count bottle, Rx Only, Manu…

Jubilant Cadista Pharmaceuticals, Inc. · Salisbury, MD

Risk level
Class II
Reported by FDA
Mar 25, 2020
Recall ID
D-1058-2020
Check your lot numberHow we source this data

Summary

Jubilant Cadista Pharmaceuticals recalled Pantoprazole Sodium Delayed-Release Tablets starting Mar 11, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1058-2020 on Mar 25, 2020. Reason: CGMP Deviations: Presence of dark brown discoloration on edges of tablets. Status: Terminated.

Why it was recalled

CGMP Deviations: Presence of dark brown discoloration on edges of tablets

Product description

Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg, 90 count bottle, Rx Only, Manufactured by Jubilant Generics Ltd, Roorkee-247661 India, NDC 59746-284-90

Lot numbers, UPCs & expiration codes

Lot # PA218005A, exp. date 12/2020, PA218P010, PA218P011, exp. date 04/2021, PA218108A, PA218110A, exp. date 06/2021

Where it was sold

Distributed Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1058-2020
Classification
Class II
Status
Terminated
Recall initiated
Mar 11, 2020
FDA report date
Mar 25, 2020
Quantity
89,376 90-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Jubilant Cadista Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-1058-2020, exactly as published.

Show all FDA fields
City
Salisbury
State
MD
Status
Terminated
Country
United States
Event ID
85181
Address
207 Kiley Dr
Code information
Lot # PA218005A, exp. date 12/2020, PA218P010, PA218P011, exp. date 04/2021, PA218108A, PA218110A, exp. date 06/2021
Postal code
21801-2249
Report date
Mar 25, 2020
Product type
Drugs
Recall number
D-1058-2020
Classification
Class II
Recalling firm
Jubilant Cadista Pharmaceuticals, Inc.
Product quantity
89,376 90-count bottles
Termination date
Jun 10, 2020
Reason for recall
CGMP Deviations: Presence of dark brown discoloration on edges of tablets
Voluntary / mandated
Voluntary: Firm initiated
Product description
Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg, 90 count bottle, Rx Only, Manufactured by Jubilant Generics Ltd, Roorkee-247661 India, NDC 59746-284-90
Distribution pattern
Distributed Nationwide in the USA
Recall initiation date
Mar 11, 2020
Initial firm notification
Letter
Center classification date
Mar 24, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1058-2020, published Mar 25, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls